v3.25.4
Significant agreements - Related Party Collaboration Receivable and Contract Liabilities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Collaboration revenue $ 40,374 $ 80,001 $ 250,008
Related party collaboration receivables, beginning balance 676    
Related party collaboration receivables, ending balance 151 676  
2023 Neurocrine Collaborative Agreement and 2019 Neurocrine Collaborative Agreement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Related party collaboration receivables, beginning balance 676    
Additions 5,204    
Deductions (5,729)    
Related party collaboration receivables, ending balance 151 676  
Deferred revenue, beginning balance 30,397    
Additions 3,000    
Deductions (31,807)    
Deferred revenue, ending balance $ 1,590 $ 30,397